Zhejiang Dayang Biotech Group Co Net Asset Momentum
Zhejiang Dayang Biotech Group Co net asset momentum. Zhejiang Dayang Biotech Group Co (003017) recorded a net asset momentum of 7.9% as of December 2025, with net assets of CN¥1.14 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Zhejiang Dayang Biotech Group Co (003017) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Zhejiang Dayang Biotech Group Co (2013–2025)
Net asset momentum of Zhejiang Dayang Biotech Group Co from 2013 to 2025. This chart tracks Zhejiang Dayang Biotech Group Co's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +7.9%, with net assets of CN¥1.14 Billion CNY as of December 2025. See Zhejiang Dayang Biotech Group Co net assets for net asset value and shareholders' equity analysis.
Zhejiang Dayang Biotech Group Co Net Asset Momentum by Year (2013–2025)
Zhejiang Dayang Biotech Group Co net asset momentum by year from 2013 to 2025. The table below shows the complete annual net asset history for Zhejiang Dayang Biotech Group Co from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Zhejiang Dayang Biotech Group Co.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.14 Billion | CN¥1.82 Billion | CN¥681.72 Million | ▲ +7.9% |
| 2024 | CN¥1.05 Billion | CN¥1.65 Billion | CN¥600.40 Million | ▲ +4.5% |
| 2023 | CN¥1.01 Billion | CN¥1.55 Billion | CN¥538.47 Million | ▲ +2.4% |
| 2022 | CN¥985.05 Million | CN¥1.51 Billion | CN¥522.92 Million | ▼ -0.6% |
| 2021 | CN¥990.71 Million | CN¥1.37 Billion | CN¥383.64 Million | ▲ +3.4% |
| 2020 | CN¥958.13 Million | CN¥1.23 Billion | CN¥270.67 Million | ▲ +92.4% |
| 2019 | CN¥498.09 Million | CN¥645.60 Million | CN¥147.51 Million | ▲ +13.0% |
| 2018 | CN¥440.62 Million | CN¥601.61 Million | CN¥160.99 Million | ▲ +30.5% |
| 2017 | CN¥337.71 Million | CN¥513.08 Million | CN¥175.37 Million | ▲ +47.2% |
| 2016 | CN¥229.35 Million | CN¥466.72 Million | CN¥237.37 Million | ▲ +9.3% |
| 2015 | CN¥209.76 Million | CN¥458.88 Million | CN¥249.12 Million | ▲ +6.6% |
| 2014 | CN¥196.87 Million | CN¥463.30 Million | CN¥266.43 Million | ▲ +5.0% |
| 2013 | CN¥187.42 Million | CN¥441.35 Million | CN¥253.93 Million | — |